atrial fibrillation

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

The company will research biomarkers linked to atrial fibrillation for a pan-European consortium funded with $17 million by the EU.

Although some industry observers suggest that Boehringer Ingelheim's newly FDA-approved anticoagulant spells the end for PGx-guided warfarin dosing, some still see opportunities where warfarin administration, made more accurate with genetic testing, may be a better option for patients.

Findings in a NEJM study this week challenged previously reported data that alleles in the CYP2C19 gene can limit how certain carriers of the polymorphisms respond to Plavix.

BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.

The deal will give cash-strapped Decode immediate access to an undisclosed sum in upfront payments, while Celera will gain access to gene markers that will expand its cardiovascular disease-focused genetic testing service.

Celera plans to use the SNPs to develop personalized risk tests for heart attack, stroke, and type 2 diabetes.

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.